All News #Library
Rare Diseases
J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma
18 Jul 2018 //
BLOOMBERG
EUSA Announces Global Rights to SYLVANT from Janssen for $115 Million
18 Jul 2018 //
BUSINESSWIRE
EUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals
11 Jul 2018 //
PR NEWSWIRE

Market Place
Sourcing Support